These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 18849137)

  • 1. Selection of the most promising 2-substituted quinoline as antileishmanial candidate for clinical trials.
    Vieira NC; Herrenknecht C; Vacus J; Fournet A; Bories C; Figadère B; Espindola LS; Loiseau PM
    Biomed Pharmacother; 2008 Dec; 62(10):684-9. PubMed ID: 18849137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antileishmanial 2-substituted quinolines: in vitro behaviour towards biological components.
    Desrivot J; Herrenknecht C; Ponchel G; Garbi N; Prina E; Fournet A; Bories C; Figadère B; Hocquemiller R; Loiseau PM
    Biomed Pharmacother; 2007 Aug; 61(7):441-50. PubMed ID: 17459651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, ADME characterization and antileishmanial evaluation of novel substituted quinoline analogs.
    Gopinath VS; Rao M; Shivahare R; Vishwakarma P; Ghose S; Pradhan A; Hindupur R; Sarma KD; Gupta S; Puri SK; Launay D; Martin D
    Bioorg Med Chem Lett; 2014 May; 24(9):2046-52. PubMed ID: 24726804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and biological evaluation of 2-substituted quinolines as potential antileishmanial agents.
    Gopinath VS; Pinjari J; Dere RT; Verma A; Vishwakarma P; Shivahare R; Moger M; Kumar Goud PS; Ramanathan V; Bose P; Rao MV; Gupta S; Puri SK; Launay D; Martin D
    Eur J Med Chem; 2013 Nov; 69():527-36. PubMed ID: 24095747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase transfer catalyzed synthesis of bis-quinolines: antileishmanial activity in experimental visceral leishmaniasis and in vitro antibacterial evaluation.
    Palit P; Paira P; Hazra A; Banerjee S; Gupta AD; Dastidar SG; Mondal NB
    Eur J Med Chem; 2009 Feb; 44(2):845-53. PubMed ID: 18538452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of oxysterols and nitrogenous sterols with antileishmanial and trypanocidal activities.
    Bazin MA; Loiseau PM; Bories C; Letourneux Y; Rault S; El Kihel L
    Eur J Med Chem; 2006 Oct; 41(10):1109-16. PubMed ID: 16949702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activities of new 2-substituted quinolines against Leishmania donovani.
    Loiseau PM; Gupta S; Verma A; Srivastava S; Puri SK; Sliman F; Normand-Bayle M; Desmaele D
    Antimicrob Agents Chemother; 2011 Apr; 55(4):1777-80. PubMed ID: 21220526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro antileishmanial activity of acetogenins from Annonaceae.
    Raynaud-Le Grandic S; Fourneau C; Laurens A; Bories C; Hocquemiller R; Loiseau PM
    Biomed Pharmacother; 2004; 58(6-7):388-92. PubMed ID: 15271421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity study of pentamidine analogues as antiprotozoal agents.
    Bakunova SM; Bakunov SA; Patrick DA; Kumar EV; Ohemeng KA; Bridges AS; Wenzler T; Barszcz T; Jones SK; Werbovetz KA; Brun R; Tidwell RR
    J Med Chem; 2009 Apr; 52(7):2016-35. PubMed ID: 19267462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of pyrazoloquinoline derivatives on the growth of Leishmania donovani promastigotes.
    Al-Qahtani A; Siddiqui YM; Bekhit AA; El-Sayed OA; Aboul-Enein HY; Al-Ahdalb MN
    Arch Pharm (Weinheim); 2005 Oct; 338(10):484-7. PubMed ID: 16211660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antileishmanial ring-substituted ether phospholipids.
    Avlonitis N; Lekka E; Detsi A; Koufaki M; Calogeropoulou T; Scoulica E; Siapi E; Kyrikou I; Mavromoustakos T; Tsotinis A; Grdadolnik SG; Makriyannis A
    J Med Chem; 2003 Feb; 46(5):755-67. PubMed ID: 12593656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo antileishmanial properties of a 2-n-propylquinoline hydroxypropyl β-cyclodextrin formulation and pharmacokinetics via intravenous route.
    Balaraman K; Vieira NC; Moussa F; Vacus J; Cojean S; Pomel S; Bories C; Figadère B; Kesavan V; Loiseau PM
    Biomed Pharmacother; 2015 Dec; 76():127-33. PubMed ID: 26653559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of chalcones as potential antileishmanial agents.
    Gupta S; Shivahare R; Korthikunta V; Singh R; Gupta S; Tadigoppula N
    Eur J Med Chem; 2014 Jun; 81():359-66. PubMed ID: 24858541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and in vitro antileishmanial activity of 5-substituted-2'-deoxyuridine derivatives.
    Peyron C; Benhida R; Bories C; Loiseau PM
    Bioorg Chem; 2005 Dec; 33(6):439-47. PubMed ID: 16168460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of orally administered 2-substituted quinolines in experimental murine cutaneous and visceral leishmaniases.
    Nakayama H; Loiseau PM; Bories C; Torres de Ortiz S; Schinini A; Serna E; Rojas de Arias A; Fakhfakh MA; Franck X; Figadère B; Hocquemiller R; Fournet A
    Antimicrob Agents Chemother; 2005 Dec; 49(12):4950-6. PubMed ID: 16304157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antileishmanial and trypanocidal activities of new miltefosine liposomal formulations.
    Papagiannaros A; Bories C; Demetzos C; Loiseau PM
    Biomed Pharmacother; 2005 Dec; 59(10):545-50. PubMed ID: 16325367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and synthesis of novel substituted quinazoline derivatives as antileishmanial agents.
    Agarwal KC; Sharma V; Shakya N; Gupta S
    Bioorg Med Chem Lett; 2009 Sep; 19(18):5474-7. PubMed ID: 19692240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxicity of betulin derivatives and in vitro effect on promastigotes and amastigotes of Leishmania infantum and L. donovani.
    Wert L; Alakurtti S; Corral MJ; Sánchez-Fortún S; Yli-Kauhaluoma J; Alunda JM
    J Antibiot (Tokyo); 2011 Jul; 64(7):475-81. PubMed ID: 21522160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antileishmanial activity of five 2- or 3- quinolines by enyne group].
    Seck M; Desrivot J; Bories C; Loiseau P; Franck X; Hocquemiller R; Figadere B; Peyrat JF; Provot O; Brion JD; Alami M
    Dakar Med; 2005; 50(3):172-5. PubMed ID: 17633005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3D-Quantitative structure-activity relationships of synthetic antileishmanial ring-substituted ether phospholipids.
    Kapou A; Benetis NP; Avlonitis N; Calogeropoulou T; Koufaki M; Scoulica E; Nikolaropoulos SS; Mavromoustakos T
    Bioorg Med Chem; 2007 Feb; 15(3):1252-65. PubMed ID: 17158053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.